Holmes S J, Lucas A H, Osterholm M T, Froeschle J E, Granoff D M
Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St Louis, Mo.
JAMA. 1991 Oct 9;266(14):1960-5.
--Haemophilus influenzae type b (Hib) conjugate vaccines are effective in preventing Haemophilus disease in most children. The reasons why the vaccination fails in some children are unknown. This study investigated host factors in children who developed the disease despite conjugate vaccination. DESIGN, PATIENTS, OUTCOME MEASURES:--A convenience sample of 23 patients in whom Hib disease developed 14 days or more after conjugate vaccination was investigated for the presence of subnormal serum immunoglobulin concentrations and anticapsular antibody responses to Hib disease. We also investigated expression of the Hib idiotype 1 (Hibld-1), a serological marker of a VKII chain that comprises a major portion of the normal variable region repertoire of the antibody response to Hib polysaccharide. The results were compared with those of 149 patients in whom the unconjugated Hib polysaccharide vaccine failed and of 90 unvaccinated patients who developed the disease.
--Compared with children in whom the unconjugated polysaccharide vaccination failed, the relative risk of a subnormal serum concentration of IgM, IgA, IgG, and/or IgG2 in the children in whom the conjugate vaccination failed was 4.9 (95% confidence interval [CI], 1.8 to 14; P less than .003) and of IgG2 was 22 (95% CI, 3.5 to 146; P less than .001). With the exception of the children with subnormal serum immunoglobulin concentrations, most of the children with conjugate vaccination failure showed normal or high anticapsular antibody responses to the disease, whereas the children with polysaccharide vaccination failure showed impaired responses. The Hibld-1 was expressed by the majority of the children in both vaccination failure groups and of the unvaccinated patients.
--In most patients, vaccination failure is not attributable to lack of expression of the variable region gene encoding Hibld-1. However, children in whom conjugate vaccination has failed frequently have subnormal serum immunoglobulin concentrations and should be evaluated for immunodeficiency.
b型流感嗜血杆菌(Hib)结合疫苗对多数儿童预防嗜血杆菌病有效。部分儿童接种疫苗后仍发病的原因尚不清楚。本研究调查了接种结合疫苗后仍发病儿童的宿主因素。
设计、患者、观察指标:选取23例接种结合疫苗14天或更长时间后发生Hib病的患者作为便利样本,调查其血清免疫球蛋白浓度是否低于正常水平以及对Hib病的抗荚膜抗体反应。我们还研究了Hib独特型1(Hibld-1)的表达情况,Hibld-1是VKII链的一种血清学标志物,该链构成了对Hib多糖抗体反应正常可变区库的主要部分。将结果与149例未结合Hib多糖疫苗接种失败的患者以及90例未接种疫苗而发病的患者进行比较。
与未结合多糖疫苗接种失败的儿童相比,结合疫苗接种失败儿童血清IgM、IgA、IgG和/或IgG2浓度低于正常水平的相对风险为4.9(95%置信区间[CI],1.8至14;P<0.003),IgG2的相对风险为22(95%CI,3.5至146;P<0.001)。除血清免疫球蛋白浓度低于正常水平的儿童外,大多数结合疫苗接种失败的儿童对该病表现出正常或高抗荚膜抗体反应,而多糖疫苗接种失败的儿童反应受损。两个疫苗接种失败组的大多数儿童以及未接种疫苗的患者均表达Hibld-1。
在大多数患者中,疫苗接种失败并非归因于编码Hibld-1的可变区基因表达缺失。然而,结合疫苗接种失败的儿童血清免疫球蛋白浓度常低于正常水平,应评估其免疫缺陷情况。